Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

OMEICOS Therapeutics GmbH
Sponsor

OMEICOS Therapeutics GmbH

Germany Robert-Roessle-Strasse 10, Buch, 13125 Berlin, Germany

About the sponsor

OMEICOS Therapeutics GmbH’s clinical research is centered on primary mitochondrial disease, with attention to patients affected by myopathy and cardiomyopathy alongside inflammation. The sponsor’s trial activity reflects interest in conditions linked to impaired mitochondrial function and multi-system involvement.

  • Myopathy
  • Cardiomyopathy
  • Inflammation

Research in this area includes evaluation of clinical responses associated with changes in GDF-15, a biomarker relevant to mitochondrial disease activity and treatment effect.

About Specializations

OMEICOS Therapeutics GmbH runs clinical trials in conditions such as Cardiomyopathy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Cardiomyopathy

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:2-{[(8Z)-13-[(Methylcarbamoyl)Formamido]-Tridec-8-En-1-Yl]Oxy}Acetic Acid
  • Sponsor:OMEICOS Therapeutics GmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.